Protalix BioTherapeutics, Inc. (PLX) Nonoperating Income (Expense) USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2024.
  • Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $123 K.
  • Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$1.29 M, a 10.4% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.89 M, a 36.9% decline from 2022.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.38 M, a 80.6% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$7.12 M, a 22.9% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.29 M $123 K +$600 K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$1.89 M -$811 K -$96 K -13.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$1.8 M $168 K +$610 K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$2.41 M -$774 K -$964 K -507% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$1.44 M -$477 K -$61 K -14.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$1.38 M -$715 K +$195 K +21.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$1.58 M -$442 K +$1.87 M +80.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$3.45 M $190 K +$2.27 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$5.72 M -$416 K +$1.41 M +77.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$7.12 M -$910 K +$1.53 M +62.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$8.65 M -$2.31 M -$459 K -24.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.19 M -$2.08 M -$165 K -8.64% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$8.03 M -$1.82 M +$1.21 M +39.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$9.23 M -$2.44 M -$533 K -27.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$8.7 M -$1.86 M +$161 K +7.99% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$8.86 M -$1.91 M -$6 K -0.32% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$8.86 M -$3.03 M -$1.3 M -74.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.56 M -$1.91 M -$147 K -8.34% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 -$7.41 M -$2.02 M -$435 K -27.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$6.98 M -$1.9 M -$186 K -10.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$6.79 M -$1.73 M +$358 K +17.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 -$7.15 M -$1.76 M +$1.96 M +52.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-30
Q3 2018 -$9.11 M -$1.58 M +$2.09 M +56.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$11.2 M -$1.72 M -$13 M -115% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.77 M -$2.09 M +$50.7 M +96% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 -$48.9 M -$3.72 M -$9.82 M -161% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$39.1 M -$3.67 M -$3.03 M -472% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 -$36.1 M $11.3 M +$12.1 M Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 -$48.1 M -$52.8 M -$52.1 M -7873% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 $3.99 M $6.1 M +$6.97 M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$2.98 M -$642 K +$371 K +36.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$3.35 M -$805 K -$206 K -34.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$3.15 M -$662 K +$467 K +41.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$3.61 M -$871 K +$517 K +37.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$4.13 M -$1.01 M +$789 K +43.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.92 M -$599 K +$73 K +10.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$4.99 M -$1.13 M -$252 K -28.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$4.74 M -$1.39 M -$651 K -88.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$4.09 M -$1.8 M -$1.7 M -1667% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$2.39 M -$672 K -$729 K -1279% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$1.66 M -$877 K -$985 K -912% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$674 K -$737 K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 -$102 K -$183 K -226% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $57 K +$35 K +159% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $108 K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q3 2012 $81 K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $22 K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.